KR900701814A - 뉴클레오사이드 동족체 - Google Patents

뉴클레오사이드 동족체

Info

Publication number
KR900701814A
KR900701814A KR1019900701554A KR900701554A KR900701814A KR 900701814 A KR900701814 A KR 900701814A KR 1019900701554 A KR1019900701554 A KR 1019900701554A KR 900701554 A KR900701554 A KR 900701554A KR 900701814 A KR900701814 A KR 900701814A
Authority
KR
South Korea
Prior art keywords
valinyl
phosphate
nucleoside
methoxy
substituted
Prior art date
Application number
KR1019900701554A
Other languages
English (en)
Korean (ko)
Inventor
맥귀간 크리스토퍼
Original Assignee
원본미기재
메디칼 리써어치 카운실
유니버시티 칼리지 런던
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 메디칼 리써어치 카운실, 유니버시티 칼리지 런던 filed Critical 원본미기재
Publication of KR900701814A publication Critical patent/KR900701814A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019900701554A 1988-11-23 1989-11-23 뉴클레오사이드 동족체 KR900701814A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8827337.0 1988-11-23
GB888827337A GB8827337D0 (en) 1988-11-23 1988-11-23 Nucleoside analogues
PCT/GB1989/001401 WO1990005736A2 (en) 1988-11-23 1989-11-23 Nucleoside analogues

Publications (1)

Publication Number Publication Date
KR900701814A true KR900701814A (ko) 1990-12-04

Family

ID=10647305

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701554A KR900701814A (ko) 1988-11-23 1989-11-23 뉴클레오사이드 동족체

Country Status (8)

Country Link
EP (1) EP0445201A1 (da)
JP (1) JPH04502006A (da)
KR (1) KR900701814A (da)
AU (1) AU626360B2 (da)
DK (1) DK95791A (da)
FI (1) FI912489A0 (da)
GB (1) GB8827337D0 (da)
WO (1) WO1990005736A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
CA2164717C (en) * 1993-06-10 2009-10-20 Louis S. Kucera Method of combatting hepatitis b virus infection
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
WO1996006620A2 (en) 1994-08-29 1996-03-07 Wake Forest University Lipid analogs for treating viral infections
WO1997021452A2 (en) * 1995-12-14 1997-06-19 Advanced Magnetics, Inc. Macromolecular prodrugs of nucleotide analogs
WO1999049873A1 (en) * 1998-03-27 1999-10-07 Regents Of The University Of Minnesota Nucleosides with antiviral and anticancer activity
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
EP1423976A1 (en) 2001-08-31 2004-06-02 Thomson Licensing S.A. Sequence counter for an audio visual stream
EP1827460A4 (en) 2004-12-09 2012-03-14 Univ Minnesota NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1414252A (en) * 1921-12-29 1922-04-25 William A Brubaker Cushion tire
US3082203A (en) * 1960-02-10 1963-03-19 American Cyanamid Co Novel nucleotide coenzymes
US3280104A (en) * 1964-04-13 1966-10-18 Syntex Corp 2', 3'-dideoxyribonucleoside and 2', 3'-dideoxyribonucleotide derivatives
US3284440A (en) * 1964-06-12 1966-11-08 Merck & Co Inc Phosphate esters of cytosine arabinoide and process for preparing same
US3534017A (en) * 1967-03-14 1970-10-13 Kyowa Hakko Kogyo Kk Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates
DE2460051A1 (de) * 1974-12-19 1976-07-01 Bayer Ag Einteilige pannensichere reifen
DE3101408A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Fahrzeugreifen
DE3148313C2 (de) * 1981-12-07 1983-11-03 Paul Vom Stein & Co, 5632 Wermelskirchen Laufrolle für Apparate, Möbel od. dgl.
KR930007211B1 (ko) * 1984-04-16 1993-08-04 유니로이알 인코포레이팃드 비 공기 타이어(non-pneumatic tire)
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
DK167377B1 (da) * 1985-09-17 1993-10-25 Wellcome Found 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion

Also Published As

Publication number Publication date
FI912489A0 (fi) 1991-05-22
AU4654289A (en) 1990-06-12
DK95791D0 (da) 1991-05-22
JPH04502006A (ja) 1992-04-09
WO1990005736A2 (en) 1990-05-31
WO1990005736A3 (en) 1990-07-12
DK95791A (da) 1991-05-22
AU626360B2 (en) 1992-07-30
GB8827337D0 (en) 1988-12-29
EP0445201A1 (en) 1991-09-11

Similar Documents

Publication Publication Date Title
DE69929060D1 (de) Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus
DK330685D0 (da) Kombinationspraeparat og dets anvendelse
AR035711A1 (es) Prodrogas 3' de 2'-desoxi-beta-l-nucleosidos; sus composiciones farmaceuticas; metodo para el tratamiento o profilaxis de una infeccion del virus de la hepatitis b y sus usos para la manufactura de composiciones farmaceuticas
DE68921760D1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
DE59108477D1 (de) Pharmazeutische zubereitungsformen
KR900701814A (ko) 뉴클레오사이드 동족체
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
KR890006624A (ko) 디데옥시시티딘 유도체
DE69031340D1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
SE8102456L (sv) Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin
KR900003105A (ko) N-2,3-부타디엔일 트리- 및 테트라아미노알칸 유도체
KR950701638A (ko) 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues)
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
KR890006625A (ko) 2,2-디메틸크로멘 유도체, 그의 제조방법 및 그것을 함유하는 약학 조성물
ATE55248T1 (de) Arzneimittelkombination.
EP0210753A3 (en) Anti-tumor medicament
KR900014385A (ko) 제약학적 치료
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
KR890012942A (ko) 5-치환된 오르니틴 유도체
KR910005886A (ko) 안정화 백혈구 인터페론
KR890002128A (ko) 실비빈의 가용성 유도체, 그것의 제조방법 및 그것을 함유하는 제약학적 조성물
EP0129891A3 (en) New quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
KR880004810A (ko) 소화성 궤양 치료제
BR9610878A (pt) Composição farmacêutica para administração intravenosa a um paciente e processo para inibir a agregaçao de plaquetas sanguíneas em mamiferos

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid